Wnt Pathway Inhibition Alleviates Symptoms of Knee Osteoarthritis
In this phase 2 clinical trial, 455 adults with Kellgren-Lawrence grades 2 to 3 knee osteoarthritis were randomly assigned to a single injection of SM04690 or placebo.
In this phase 2 clinical trial, 455 adults with Kellgren-Lawrence grades 2 to 3 knee osteoarthritis were randomly assigned to a single injection of SM04690 or placebo.
In patients with opioid-induced constipation, naldemedine was shown to improve patient assessment of symptoms and quality of life.